{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T07:18:33Z","timestamp":1772954313671,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81273118"],"award-info":[{"award-number":["81273118"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.cbi.2016.12.015","type":"journal-article","created":{"date-parts":[[2016,12,24]],"date-time":"2016-12-24T12:48:02Z","timestamp":1482583682000},"page":"55-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["ERCC2\/XPD Lys751Gln alter DNA repair efficiency of platinum-induced DNA damage through P53 pathway"],"prefix":"10.1016","volume":"263","author":[{"given":"Guopei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangyang","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuejiao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahar","family":"van der Straaten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sha","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guolian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiufang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuihong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinghua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengwen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobo","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"26","key":"10.1016\/j.cbi.2016.12.015_bib1","first-page":"4261","article-title":"Irinotecan plus carboplatin versus oral etoposide plus carboplatin in exensive small - cell lung cancer: a randomized phase \u2162 trial[J]","volume":"26","author":"Hermes","year":"2008","journal-title":"Clin. Oncol."},{"issue":"4","key":"10.1016\/j.cbi.2016.12.015_bib2","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s10147-007-0757-8","article-title":"Chemotherapy with prgylated liposomal doxorubicin and cisplatin in recurrent platinum - sensitive epithelial ovarian cancer[J]","volume":"13","author":"Tas","year":"2008","journal-title":"Int. J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.cbi.2016.12.015_bib3","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/ijc.24126","article-title":"DNA repair phenotype and cancer susceptibility-a mini review[J]","volume":"124","author":"Li","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.cbi.2016.12.015_bib4","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1056\/NEJMp068308","article-title":"DNA repair and survival in lung cancer-the two faces of Janus[J]","volume":"356","author":"Gazdar","year":"2007","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cbi.2016.12.015_bib5","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1126\/science.7801121","article-title":"Transcription-coupled repair and human disease[J]","volume":"266","author":"HanawaltPC","year":"1994","journal-title":"Science"},{"issue":"43","key":"10.1016\/j.cbi.2016.12.015_bib6","doi-asserted-by":"crossref","first-page":"33260","DOI":"10.1074\/jbc.M004764200","article-title":"p44\/SSL1, the regulatory subunit of the XPD\/RAD3 helicase, plays a crucial role in the transcriptional activity of TFIIH[J]","volume":"275","author":"T1","year":"2000","journal-title":"Biol. Chem."},{"issue":"6","key":"10.1016\/j.cbi.2016.12.015_bib7","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/mutage\/17.6.463","article-title":"ERCC2\/XPD gene polymorphisms and cancer risk[J]","volume":"17","author":"Benhamou","year":"2002","journal-title":"Mutagenesis"},{"key":"10.1016\/j.cbi.2016.12.015_bib8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0968-0004(96)10050-5","article-title":"The role of general initiation factors in transcription by RNA polymerase II[J]","volume":"9","author":"Roeder","year":"1996","journal-title":"Trends Biochem. Sci."},{"issue":"4","key":"10.1016\/j.cbi.2016.12.015_bib9","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.bbrc.2012.02.097","article-title":"XPD could suppress growth of HepG2.2.15 and down-regulate the expression of hepatitis B virus x protein through P53 pathway[J]","volume":"419","author":"Ding","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.cbi.2016.12.015_bib10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1476-4598-4-18","article-title":"ABCC5, ERCC2, XPA and XRCC1 transcript abundancelevels correlate with cisplatin chemoresistance in non-small cell lung cancercell lines[J]","volume":"4","author":"Weaver","year":"2005","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cbi.2016.12.015_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/aje\/kwi018","article-title":"ERCC2\/XPD gene polymorphisms and lung cancer: a HuGE review[J]","volume":"161","author":"Benhamou","year":"2005","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.cbi.2016.12.015_bib12","first-page":"1513","article-title":"Polymorphisms in DNA repair genes and associations with cancer risk[J]","volume":"11","author":"Goode","year":"2002","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.cbi.2016.12.015_bib13","first-page":"77","article-title":"Polymorphisms in the DNA repair gene XPD: correlations with risk and age at onset of basal cell carcinoma[J]","volume":"8","author":"Dybdahl","year":"1999","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.cbi.2016.12.015_bib14","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/2491","article-title":"Mutations in the XPD helicase gene result in XP and TTD phenotypes, preventing interaction between XPD and the p44 subunit of TFIIH[J]","volume":"20","author":"Coin","year":"1998","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.cbi.2016.12.015_bib15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cancergencyto.2004.01.027","article-title":"Polymorphisms in the DNA repair gene XPD and susceptibility to esophageal squamous cell carcinoma[J]","volume":"154","author":"Yu","year":"2004","journal-title":"Cancer Genet. Cytogenet"},{"key":"10.1016\/j.cbi.2016.12.015_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0093-7754(03)00281-1","article-title":"Targeted therapy in combination with gemcitabine in non-small cell lung cancer[J]","volume":"30","author":"Rosell","year":"2003","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.cbi.2016.12.015_bib17","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1097\/JTO.0b013e318155a637","article-title":"ERCC1 mRNA expression is not associated with response and survival after platinum-based chemotherapy regimens in advanced non-small cell lung cancer[J]","volume":"2","author":"Booton","year":"2007","journal-title":"Thorac. Oncol."},{"issue":"4","key":"10.1016\/j.cbi.2016.12.015_bib18","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrd1691","article-title":"Cellular processing of platinum anticancer drugs","volume":"4","author":"Wang","year":"2005","journal-title":"Nat. Rev. Drug Discov.[J]"},{"issue":"4","key":"10.1016\/j.cbi.2016.12.015_bib19","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1124\/mol.59.4.657","article-title":"Is cisplatin-induced cell deathalways produced by apoptosis[J]","volume":"59","author":"Gonzalez","year":"2001","journal-title":"Mol. Pharmacol."},{"issue":"19","key":"10.1016\/j.cbi.2016.12.015_bib20","doi-asserted-by":"crossref","first-page":"5293","DOI":"10.1093\/emboj\/cdg489","article-title":"The comings and goings of nucleotideexcision repair factors on damaged DNA[J]","volume":"22","author":"Riedl","year":"2003","journal-title":"EMBO"},{"issue":"8","key":"10.1016\/j.cbi.2016.12.015_bib21","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.7314\/APJCP.2012.13.8.3821","article-title":"Association of four ERCC1 and ERCC2 SNPs with survival ofbone tumour patients[J]","volume":"13","author":"Hao","year":"2012","journal-title":"Asian pac. J. Cancer Prev."},{"issue":"4","key":"10.1016\/j.cbi.2016.12.015_bib22","first-page":"1354","article-title":"Modulation of nucleotide excision repair capacity by XPDpolymorphisms in lung cancer patients[J]","volume":"61","author":"Spitz","year":"2001","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.cbi.2016.12.015_bib23","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.tiv.2016.04.015","article-title":"The ERCC2\/XPD Lys751Gln polymorphism affects DNA repair of benzo[a]pyrene induced damage, tested in an in\u00a0vitro model[J]","volume":"34","author":"Xiaoa","year":"2016","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.cbi.2016.12.015_bib24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/mutage\/gem041","article-title":"The role of P53 in DNA damage-mediated cytotoxicity overrides its ability to regulate nucleotide excision repair in human fibroblasts[J]","volume":"23","author":"Bhana","year":"2008","journal-title":"Mutagenesis"},{"key":"10.1016\/j.cbi.2016.12.015_bib25","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J","article-title":"Single cell gel\/comet assay: guidelines for in\u00a0vitro and in\u00a0vivo genetic toxicology testing[J]","volume":"35","author":"Tice","year":"2000","journal-title":"Environ. Mol. Mutagen."},{"issue":"32","key":"10.1016\/j.cbi.2016.12.015_bib26","doi-asserted-by":"crossref","first-page":"5002","DOI":"10.1038\/sj.onc.1205656","article-title":"Impaired DNA damage-induced nuclear Rad51 foci formation uniquely characterizes Fanconi anemia group D1[J]","volume":"21","author":"Godthelp","year":"2002","journal-title":"Oncogene"},{"issue":"1\u20132","key":"10.1016\/j.cbi.2016.12.015_bib27","first-page":"79","article-title":"Chinese hamster cell mutant, V-C8, a model for analysis of Brca2 function[J]","volume":"600","author":"Wouter","year":"2006","journal-title":"Mutat. Res."},{"issue":"26","key":"10.1016\/j.cbi.2016.12.015_bib28","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1200\/JCO.2007.15.7545","article-title":"Irinotecan plus carbopletin versus oral etoposide plus carboplatin in extensive small-cell lung cancer: a randomized phase \u2162 trial[J]","volume":"26","author":"Hermes","year":"2008","journal-title":"J.\u00a0Clin. Oncol."},{"issue":"4","key":"10.1016\/j.cbi.2016.12.015_bib29","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1158\/1078-0432.CCR-05-0024","article-title":"Nucleotide excision repair, oxidative damage, DNAsequence polymorphisms, and cancer treatment[J]","volume":"11","author":"Hutsell","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"17","key":"10.1016\/j.cbi.2016.12.015_bib30","first-page":"4899","article-title":"Transcription-coupled nucleotide excision repair as a determinantof cisplatin sensitivity of human cells[J]","volume":"62","author":"Furuta","year":"2002","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.cbi.2016.12.015_bib31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1053\/j.seminoncol.2003.12.011","article-title":"Molecular predictors of response tochemotherapy in lung cancer[J]","volume":"31","author":"Rosell","year":"2004","journal-title":"Semin. Oncol."},{"issue":"1","key":"10.1016\/j.cbi.2016.12.015_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1349-7006.2003.tb01345.x","article-title":"Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signa[J]","volume":"94","author":"Tsuruo","year":"2003","journal-title":"Cancer Sci."},{"issue":"5","key":"10.1016\/j.cbi.2016.12.015_bib33","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/carcin\/bgs107","article-title":"Deciphering the role of the ERCC2 gene polymorphism on anticancer drug sensitivity[J]","volume":"33","author":"Moisan","year":"2012","journal-title":"Carcinogenesis"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279716307530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279716307530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:41:46Z","timestamp":1757857306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279716307530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":33,"alternative-id":["S0009279716307530"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2016.12.015","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ERCC2\/XPD Lys751Gln alter DNA repair efficiency of platinum-induced DNA damage through P53 pathway","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2016.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}